Elixirr International plc (LON:ELIX – Get Free Report) insider Stephen Alexander Newton sold 270,270 shares of the stock in a transaction that occurred on Friday, January 17th. The stock was sold at an average price of GBX 740 ($9.11), for a total value of £1,999,998 ($2,462,142.07).
Elixirr International Trading Up 0.6 %
Shares of LON:ELIX opened at GBX 730 ($8.99) on Thursday. Elixirr International plc has a 1 year low of GBX 510 ($6.28) and a 1 year high of GBX 810 ($9.97). The firm has a fifty day moving average price of GBX 746.54 and a 200 day moving average price of GBX 666.74. The stock has a market capitalization of £342.66 million, a PE ratio of 2,027.78 and a beta of 0.63. The company has a current ratio of 1.51, a quick ratio of 1.29 and a debt-to-equity ratio of 3.90.
Elixirr International Cuts Dividend
The business also recently disclosed a dividend, which will be paid on Monday, February 17th. Investors of record on Thursday, January 23rd will be paid a GBX 6.30 ($0.08) dividend. This represents a dividend yield of 0.87%. The ex-dividend date of this dividend is Thursday, January 23rd. Elixirr International’s payout ratio is 4,166.67%.
Elixirr International Company Profile
We’re an award-winning, global consulting firm working with clients across a diverse range of markets, industries and geographies. In short, we take on our clients’ toughest challenges, building businesses that redefine industries.
We’re a high-performance, hand-selected team of industry professionals, subject matter experts, career consultants, designers and developers.
Further Reading
- Five stocks we like better than Elixirr International
- Election Stocks: How Elections Affect the Stock Market
- Oracle Announces Game-Changing News for the AI Industry
- Compound Interest and Why It Matters When Investing
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- The Risks of Owning Bonds
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for Elixirr International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elixirr International and related companies with MarketBeat.com's FREE daily email newsletter.